Research of Hepatitis B Virus and Related Disease in the United States: Key Findings from the NIDDK Hepatitis B Research Network
The 11th webinar in the "Moving for Hepatitis Discovery to Elimination" series is hosted by National Institute of Diabetes and Digestive Diseases (NIDDK).
The Hepatitis B Research Network (HBRN) was a multicenter network established by NIDDK to investigate the etiology and progression of hepatitis B (HBV) and to test the safety and efficacy of current therapies. Join this webinar to learn of highlights from the research conducted by the Network.
Welcome and Introductions | Jay Hoofnagle and John Ward
Anna Lok, University of Michigan | Chronic hepatitis B in the US: clinical features, natural history and outcomes
Will Lee, University of Texas Southwestern | Acute hepatitis B: clinical features of 60 US Cases
Norah Terrault, University of Southern California | Treatment Strategies to Increase HBsAg Loss: Outcomes from the HBRN Immune Active Trial
Round table discussion:
- Patrizia Farci, NIAID/NIH
- Paul Skip Hayashi, FDA
- Brian McMahon, US CDC